BG
AH

BlackRock Group’s Accretive Health AH Stock Holding History

BlackRock Group’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-26,913
Closed -$247K – 2779
2013
Q4 		$247K Hold
26,913
– – ﹤0.01% 2380
2013
Q3 		$245K Hold
26,913
– – ﹤0.01% 2443
2013
Q2 		$291K Buy
+26,913
New +$283K ﹤0.01% 2199

Other funds holding AH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

BlackRock Group's AH Position: Q1 2014 in Review

BlackRock Group sold out of Accretive Health (AH) in Q1 2014, closing a stake of 26,913 shares — an estimated $247K sold.

BlackRock Group first reported a position in AH in Q2 2013 and held it in 3 quarters. The position peaked at $291K in Q2 2013. 66 funds tracked by Wall St. Rank hold AH as of Q1 2014.

  • BlackRock Group reported no remaining Accretive Health position as of Q1 2014 after selling out during the quarter.
  • BlackRock Group sold 26,913 Accretive Health shares in Q1 2014, an estimated $247K.
  • BlackRock Group first reported a position in Accretive Health in Q2 2013 and held it in 3 quarters.
  • BlackRock Group's Accretive Health position peaked at $291K in Q2 2013.
  • 66 funds tracked by Wall St. Rank held Accretive Health as of Q1 2014.

Based on BlackRock Group's 13F filing for Q1 2014, filed 2 May 2014.